Streptococcus pneumoniae arginine synthesis genes promote growth and virulence in pneumococcal meningitis

Jurgen R Piet1, Madelijn Geldhoff, Barbera D C van Schaik

  • 1Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, P.O. Box 22660, Amsterdam 1100 DD, the Netherlands.

Insights

Streptococcus pneumoniae arginine synthesis genes enhance bacterial growth and virulence in invasive infections like meningitis and pneumonia. These findings highlight a key factor in pneumococcal disease progression.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • Streptococcus pneumoniae (pneumococcus) is a significant cause of pneumonia, sepsis, and bacterial meningitis.
  • Understanding the genetic factors influencing pneumococcal virulence is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of pneumococcal arginine biosynthesis genes in the outcome of pneumococcal meningitis.
  • To determine the impact of these genes on bacterial growth and virulence in vivo.

Main Methods:

  • Clinical phenotype-based approach combined with whole-genome sequencing of Streptococcus pneumoniae.
  • In vitro growth assays using human blood and cerebrospinal fluid (CSF).
  • Murine models of meningitis and pneumonia to assess bacterial attenuation and clearance.

Main Results:

  • Pneumococcal strains with arginine biosynthesis genes exhibited increased growth in human blood and CSF.
  • Strains lacking these genes were attenuated in growth and cleared from lung, blood, and CSF in mouse models.
  • Arginine biosynthesis genes are associated with improved patient outcomes in pneumococcal meningitis.

Conclusions:

  • Streptococcus pneumoniae arginine synthesis genes are critical for promoting bacterial growth and virulence in invasive pneumococcal disease.
  • Targeting arginine biosynthesis pathways could be a potential therapeutic strategy against pneumococcal infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
954
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
76
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
4.7K